Integrated Micro-Electronics, Inc. (PSE:IMI)

Inozyme Pharma Revenue

Integrated Micro-Electronics had revenue of $248.69M USD in the quarter ending June 30, 2025, a decrease of -9.79%. This brings the company's revenue in the last twelve months to $1.03B, down -14.13% year-over-year. In the year 2024, Integrated Micro-Electronics had annual revenue of $1.10B, down -17.22%.

• Revenue (ttm): $1.03B
• Revenue Growth: -14.13%
• P/S Ratio: 0.08
• Revenue / Employee: $59.83K
• Employees: 17,215
• Market Cap: 4.92B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.10B	-228.52M	-17.22%
Dec 31, 2023	1.33B	-81.80M	-5.81%
Dec 31, 2022	1.41B	108.43M	8.34%
Dec 31, 2021	1.30B	164.75M	14.50%
Dec 31, 2020	1.14B	-114.53M	-9.16%